Endothelial Dysfunction: a Novel Therapeutic Target
Secondary Endothelial Dysfunction: Hypertension and Heart Failure

https://doi.org/10.1006/jmcc.1998.0842Get rights and content

Abstract

The endothelium is a major regulator of vascular tone, releasing vasoactive substances such as endothelium-derived nitric oxide (EDRF), endothelium-derived hyperpolarizing factor(s), cyclooxygenase metabolites, endothelin and other endothelium-derived contracting factors (EDCF). In a number of cardiovascular pathologies, such as hypertension or heart failure, the balance in the endothelial production of vasodilating and vasoconstricting mediators is altered. The resulting apparent decrease in endothelium-dependent relaxations is termed «endothelial dysfunction». In hypertensive patients and in animal models of hypertension, endothelium-dependent relaxations are impaired. However, this endothelial dysfunction presents different characteristics depending on the model studied. In Dahl-salt-sensitive rats, the decrease in endothelium-dependent relaxations is associated with impaired constitutive nitric oxide synthase activity. The presence of an endogenous nitric oxide synthase inhibitor and a decreased response of vascular smooth muscle to the mediator may contribute also to the dysfunction observed in this model. In other animal models of hypertension (such as spontaneous hypertension), the contribution of thel-arginine nitric oxide pathway to endothelium-dependent responses appears normal or impaired despite reports of increased nitric oxide synthase activity or expression. In large arteries from SHR, endothelium-dependent relaxations are impaired mainly because of the concomitant augmented release of endoperoxides activating thromboxane–endoperoxide receptors. Superoxide anions may also play a role in some models, but only in the early phase of the disease; whether or not these species contribute to further development of endothelial dysfunction or to increases in blood pressure remains to be examined. The endothelial dysfunction observed in hypertension is likely to be a consequence of high blood pressure, but it could facilitate the maintenance of elevated peripheral resistance at a later stage in the disease and favour the occurrence of complications, such as atherosclerosis.

References (0)

Cited by (156)

  • General Treatment of Heart Failure With Preserved Ejection Fraction and Randomized Trials

    2020, Diastology: Clinical Approach to Heart Failure with Preserved Ejection Fraction
  • Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)

    2019, American Journal of Cardiology
    Citation Excerpt :

    Our findings are consistent with a previous META-analysis showing that the association between PRU and the risk of adverse ischemic outcomes was stronger among patients with versus without hypertension and other cardiovascular risk factors.11 Hypertension is association with endothelial inflammation and dysfunction.6–8 Given the central role of endothelial cells in suppressing platelet adhesion and maintaining normal platelet function, dysfunctional coronary endothelium would be expected to promote platelet adhesion and activation.4,5

View all citing articles on Scopus
View full text